Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Angier

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Bulletin of the Medical Library Association|July 1, 1984
Issues in consumer mental health informationJ J Angier
Methods in Molecular Medicine|February 19, 2011
Herpesvirus protease assaysP Ertl, L Russell, J Angier
Annals of the New York Academy of Sciences|January 1, 1989
Structure, expression, and protein engineering of the pyruvate dehydrogenase complex of Escherichia coliJ R Guest, S J Angier, G C Russell
Bulletin of the Medical Library Association|January 1, 1990
Use of the PDQ system in a clinical settingJ J Angier, S L Beck, H J Eyre
Journal of Mass Spectrometry : JMS|January 6, 1999
Investigation of the covalent modification of the catalytic triad of human cytomegalovirus protease by pseudo-reversible beta-lactam inhibitors and a peptide chloromethylketoneT M Haley, S J Angier, A D Borthwick, et al.
Journal of Medicinal Chemistry|November 23, 2000
Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxo-hexahydro-pyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 1. The alpha-methyl-trans-lactam templateA D Borthwick, S J Angier, A J Crame, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Bulletin of the Medical Library Association|July 1, 1984
Issues in consumer mental health informationJ J Angier
Methods in Molecular Medicine|February 19, 2011
Herpesvirus protease assaysP Ertl, L Russell, J Angier
Annals of the New York Academy of Sciences|January 1, 1989
Structure, expression, and protein engineering of the pyruvate dehydrogenase complex of Escherichia coliJ R Guest, S J Angier, G C Russell
Bulletin of the Medical Library Association|January 1, 1990
Use of the PDQ system in a clinical settingJ J Angier, S L Beck, H J Eyre
Journal of Mass Spectrometry : JMS|January 6, 1999
Investigation of the covalent modification of the catalytic triad of human cytomegalovirus protease by pseudo-reversible beta-lactam inhibitors and a peptide chloromethylketoneT M Haley, S J Angier, A D Borthwick, et al.
Journal of Medicinal Chemistry|November 23, 2000
Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxo-hexahydro-pyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 1. The alpha-methyl-trans-lactam templateA D Borthwick, S J Angier, A J Crame, et al.
Pageof 1